Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.
British journal of clinical pharmacology2005Culm-Merdek KE, von Moltke LL, Harmatz JS, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
Area Under CurveCaffeineCentral Nervous System StimulantsChromatography, High Pressure LiquidCross-Over StudiesDouble-Blind MethodDrug CombinationsDrug InteractionsElectroencephalographyFemaleFluvoxamineHalf-LifeHumansMaleMiddle AgedPsychomotor PerformanceSelective Serotonin Reuptake Inhibitors
DOI 10.1111/j.1365-2125.2005.02467.x
PMID 16236038
原文・出典を見る →